551 related articles for article (PubMed ID: 36359789)
41. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease.
Salinas GF; Braza F; Brouard S; Tak PP; Baeten D
Clin Immunol; 2013 Jan; 146(1):34-45. PubMed ID: 23202542
[TBL] [Abstract][Full Text] [Related]
42. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells.
Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A
BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125
[TBL] [Abstract][Full Text] [Related]
43. Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.
Clark AG; Buckley ES; Foster MH
Eur J Immunol; 2018 Mar; 48(3):492-497. PubMed ID: 29251774
[TBL] [Abstract][Full Text] [Related]
44. TLR signaling in B-cell development and activation.
Hua Z; Hou B
Cell Mol Immunol; 2013 Mar; 10(2):103-6. PubMed ID: 23241902
[TBL] [Abstract][Full Text] [Related]
45. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
Rui L; Vinuesa CG; Blasioli J; Goodnow CC
Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
[TBL] [Abstract][Full Text] [Related]
46. B-cell subsets, signaling and their roles in secretion of autoantibodies.
Iwata S; Tanaka Y
Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
[TBL] [Abstract][Full Text] [Related]
47. CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.
Sieger N; Fleischer SJ; Mei HE; Reiter K; Shock A; Burmester GR; Daridon C; Dörner T
Arthritis Rheum; 2013 Mar; 65(3):770-9. PubMed ID: 23233360
[TBL] [Abstract][Full Text] [Related]
48. Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.
Gill R; McCabe MJ; Rosenspire AJ
Toxicol Appl Pharmacol; 2017 Sep; 330():22-29. PubMed ID: 28668464
[TBL] [Abstract][Full Text] [Related]
49. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
[TBL] [Abstract][Full Text] [Related]
50. Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
Sawabe T; Horiuchi T; Koga R; Tsukamoto H; Kojima T; Harashima S; Kikuchi Y; Otsuka J; Mitoma H; Yoshizawa S; Niho Y; Watanabe T
Genes Immun; 2003 Mar; 4(2):122-31. PubMed ID: 12618860
[TBL] [Abstract][Full Text] [Related]
51. Targeting Signaling Pathways in Chronic Lymphocytic Leukemia.
Muggen AF; Singh SP; Hendriks RW; Langerak AW
Curr Cancer Drug Targets; 2016; 16(8):669-688. PubMed ID: 27055580
[TBL] [Abstract][Full Text] [Related]
52. Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.
Liubchenko GA; Appleberry HC; Holers VM; Banda NK; Willis VC; Lyubchenko T
J Autoimmun; 2012 Jun; 38(4):293-303. PubMed ID: 22365785
[TBL] [Abstract][Full Text] [Related]
53. [Recent Advances of Researches on Expression, Function and Regulation of CD22].
Wu XJ; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):573-7. PubMed ID: 25948227
[TBL] [Abstract][Full Text] [Related]
54. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
55. Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.
O'Neill SK; Veselits ML; Zhang M; Labno C; Cao Y; Finnegan A; Uccellini M; Alegre ML; Cambier JC; Clark MR
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6262-7. PubMed ID: 19332776
[TBL] [Abstract][Full Text] [Related]
56. The role of B cells in lupus pathogenesis.
Nashi E; Wang Y; Diamond B
Int J Biochem Cell Biol; 2010 Apr; 42(4):543-50. PubMed ID: 19850148
[TBL] [Abstract][Full Text] [Related]
57. Atypical B cell receptor signaling: straddling immune diseases and cancer.
Faris M
Int Rev Immunol; 2013 Aug; 32(4):355-7. PubMed ID: 23848467
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase Cδ promotes transitional B cell-negative selection and limits proximal B cell receptor signaling to enforce tolerance.
Limnander A; Zikherman J; Lau T; Leitges M; Weiss A; Roose JP
Mol Cell Biol; 2014 Apr; 34(8):1474-85. PubMed ID: 24515435
[TBL] [Abstract][Full Text] [Related]
59. Actin-binding protein 1 links B-cell antigen receptors to negative signaling pathways.
Seeley-Fallen MK; Liu LJ; Shapiro MR; Onabajo OO; Palaniyandi S; Zhu X; Tan TH; Upadhyaya A; Song W
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9881-6. PubMed ID: 24958882
[TBL] [Abstract][Full Text] [Related]
60. Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies.
Teodorovic LS; Babolin C; Rowland SL; Greaves SA; Baldwin DP; Torres RM; Pelanda R
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):E2797-806. PubMed ID: 24958853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
